Related Experiment Videos
[Pathological fracture in primary malignant bone tumors].
F Zeifang1, D Sabo, V Ewerbeck
1Stifung Orthopädische Universitätsklinik Heidelberg.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|October 24, 2000
Summary
Pathological fractures in primary malignant bone tumors significantly increase mortality risk. However, reconstructive surgery, when performed correctly, does not negatively impact survival rates for these patients.
Area of Science:
- Orthopedics
- Oncology
- Pathology
Context:
- Primary malignant bone tumors present a significant clinical challenge.
- Pathological fractures complicate the diagnosis and treatment of bone tumors.
- Understanding fracture impact on survival is crucial for patient management.
Purpose:
- To investigate the influence of pathological fractures on survival rates in patients with primary malignant bone tumors.
- To evaluate the impact of different surgical therapies (ablative vs. reconstructive) on survival.
- To determine if pathological fractures affect the timing of diagnosis.
Summary:
- This retrospective analysis reviewed 30 patients with pathological fractures among 336 with primary malignant bone tumors.
- Pathological fractures led to diagnosis in 25 patients and were associated with malignant fibrous histiocytoma and advanced tumor stages (IIb, III).
- The mortality risk was more than double for patients with pathological fractures (P=0.0062); reconstructive surgery did not affect survival if done correctly.
Impact:
- Pathological fractures are a critical factor influencing survival in primary malignant bone tumors.
- Early diagnosis and appropriate surgical intervention are vital for improving patient outcomes.
- Reconstructive surgery offers a viable option without compromising survival when indicated.